Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortizatization of Intangibles (2023 - 2025)

Cumberland Pharmaceuticals' Amortizatization of Intangibles history spans 3 years, with the latest figure at $285185.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles changed 0.0% year-over-year to $285185.0; the TTM value through Dec 2025 reached $1.1 million, changed 0.0%, while the annual FY2025 figure was $1.1 million, 0.0% changed from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $285185.0 at Cumberland Pharmaceuticals, roughly flat from $285184.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $285185.0 in Q2 2024 and bottomed at $172209.0 in Q1 2023.
  • The 3-year median for Amortizatization of Intangibles is $285184.0 (2024), against an average of $272631.7.
  • The largest annual shift saw Amortizatization of Intangibles surged 65.6% in 2024 before it changed 0.0% in 2025.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $172209.0 in 2023, then soared by 65.6% to $285185.0 in 2024, then changed by 0.0% to $285185.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Amortizatization of Intangibles are $285185.0 (Q4 2025), $285184.0 (Q3 2025), and $285185.0 (Q2 2025).